Durgical
EN
Open the app

Pulmonary alveolar proteinosis

A rare disease in which surfactant piles up in the air sacs because the cells that clear it fail. It causes slow breathlessness; washing out the lungs helps.

Updated

What it is

A rare syndrome in which surfactant lipids and proteins accumulate in the alveoli because alveolar macrophages cannot clear them, filling the air spaces and impairing gas exchange. Most cases are autoimmune, caused by antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF).

Who gets it

Rare, with a prevalence of a few cases per million people. About 90% are autoimmune; it usually appears between 30 and 50 years of age, is more frequent in men, and most patients have smoked. Secondary forms occur with blood cancers or heavy dust exposure, and hereditary forms mainly in infants and children.

Causes

  • Autoimmune: neutralising anti-GM-CSF autoantibodies (most cases)
  • Secondary: blood disorders (myelodysplastic syndrome, myeloid leukaemia), GATA2 deficiency, immunodeficiency and immunosuppression
  • Secondary: heavy inhalation of silica (acute silicoproteinosis), aluminium, indium, titanium or other dusts and fumes
  • Hereditary: mutations in the GM-CSF receptor (CSF2RA, CSF2RB)
  • Congenital surfactant production disorders (SFTPB, SFTPC, ABCA3, NKX2-1), which are a different, mainly paediatric disease that looks similar

Risk factors

  • Smoking
  • Occupational dust and fume exposure (sandblasting, mining, stone cutting, metalworking)
  • Myelodysplastic syndrome and other myeloid disorders
  • Male sex, middle age

Pathophysiology

Type II pneumocytes secrete surfactant continuously → alveolar macrophages normally take up and break down most of it, but only while GM-CSF, acting through the transcription factor PU.1, keeps them mature → in autoimmune disease antibodies neutralise GM-CSF; in hereditary disease its receptor is defective; in secondary disease the macrophages are damaged or too few → surfactant piles up, macrophages become swollen and foamy, and alveoli fill with periodic acid-Schiff (PAS)-positive material while the interstitium stays largely normal → blood passing the filled alveoli is not oxygenated (shunt), so hypoxaemia and a low diffusing capacity follow → the same failing macrophages and neutrophils fight microbes poorly, so Nocardia, mycobacteria and fungi take hold.

Classification

  • Primary: autoimmune (anti-GM-CSF antibodies) and hereditary (GM-CSF receptor defects)
  • Secondary: haematological, inhaled dust, infection, immunodeficiency
  • Congenital surfactant production disorders (separate category, mostly children)
  • By severity: from radiographic disease without symptoms to hypoxaemic respiratory failure

Symptoms and signs

  • Slowly progressive breathlessness on exertion
  • Dry cough, sometimes with whitish or gummy sputum
  • Fatigue and weight loss
  • Some people have no symptoms despite marked radiographic changes
  • Fever suggests a superimposed infection
  • Few signs: crackles are uncommon; cyanosis and clubbing in advanced disease

Diagnosis

Clinical
Suspected in a middle-aged person, often a smoker, with slowly progressive breathlessness and diffuse opacities that look worse on imaging than the symptoms suggest; occupational exposures and blood disorders are asked about.
Tests
Serum anti-GM-CSF antibody testing is highly sensitive and specific for autoimmune proteinosis; when negative, serum GM-CSF levels and genetic testing look for hereditary forms. Bronchoalveolar lavage returns milky, opaque fluid with PAS-positive material and foamy macrophages; transbronchial or cryobiopsy, or rarely surgical biopsy, is needed only when the diagnosis is unclear. Pulmonary function shows a disproportionate fall in diffusing capacity and often a restrictive pattern; oximetry or arterial blood gas measures hypoxaemia. Serum LDH and other markers (KL-6, CEA) are often raised; a blood count screens for a haematological cause; cultures look for infection.
Imaging
Chest radiograph shows bilateral, symmetrical, mainly perihilar airspace opacities (bat-wing pattern) without effusions or cardiomegaly. High-resolution CT shows ground-glass opacity with thickened interlobular septa (crazy paving) and sharp, geographic borders with spared lobules.

Differential diagnosis

Bilateral ground glass and crazy paving: alveolar proteinosis and its mimics

ConditionCourseDistinguishing findingBronchoalveolar lavage
Pulmonary alveolar proteinosisSlow, over months; symptoms milder than the imagingGeographic crazy paving with spared lobules; anti-GM-CSF antibodiesMilky, opaque; PAS-positive material and foamy macrophages
Pneumocystis pneumoniaSubacute, days to weeks; fever, oxygen falls on exertionImmunosuppression (HIV, corticosteroids), high LDHOrganisms on silver stain or PCR
Cardiogenic pulmonary oedemaHours to daysLarge heart, effusions, septal lines, quick response to diureticsRarely needed
Diffuse alveolar haemorrhageAcute; haemoptysis and falling haemoglobinVasculitis or kidney involvementIncreasingly bloody returns; haemosiderin-laden macrophages

Goal of treatment

Clear the alveoli to restore gas exchange, correct the underlying cause of macrophage failure, prevent and treat infection, and avoid further exposure.

Treatment

Follow-up
People with mild disease and few symptoms are followed with symptoms, oximetry, lung function and imaging; some remit spontaneously.
Procedure
Whole-lung lavage, the standard treatment for symptomatic disease: under general anaesthesia with a double-lumen tube, one lung is ventilated while the other is repeatedly filled with warmed saline and drained, with chest percussion, until the fluid clears; the other lung follows in the same or a later session.
Medical
Inhaled recombinant GM-CSF (sargramostim, molgramostim) for autoimmune proteinosis improves oxygenation and may reduce the need for lavage; availability varies by country. Rituximab or plasmapheresis has been tried in refractory cases with limited evidence.
Medical
Secondary forms: treat the cause, for example removal from dust exposure or treatment of the blood disorder; haematopoietic stem cell transplantation for GATA2 deficiency or hereditary receptor defects in selected patients.
Lifestyle
Stop smoking and avoid occupational dusts; vaccination against influenza and pneumococcus; prompt treatment of infections.
Surgical
Lung transplantation for end-stage disease or congenital surfactant disorders; the autoimmune form can recur in the transplanted lung.

Complications

  • Hypoxaemic respiratory failure
  • Opportunistic infections: Nocardia, Mycobacterium (tuberculous and non-tuberculous), Aspergillus, Cryptococcus, Histoplasma
  • Pulmonary fibrosis (uncommon)
  • Complications of lavage: transient worse hypoxaemia, fluid leak into the pleura, pneumothorax

Common traps

  • Alveolar proteinosis is a disease of surfactant overproduction: in adults production is normal; clearance fails because the macrophages lack GM-CSF signalling
  • Crazy paving on CT means alveolar proteinosis: it also appears with pulmonary oedema, Pneumocystis, alveolar haemorrhage, ARDS and mucinous adenocarcinoma; anti-GM-CSF antibodies and lavage confirm it
  • Fever is part of the disease: proteinosis itself rarely causes fever; fever points to an opportunistic infection such as Nocardia, mycobacteria or fungi
  • Imaging this extensive means the patient must be very ill: symptoms are often milder than the CT suggests, and some patients have none
  • Congenital surfactant gene defects are the childhood form of the same disease: SFTPB, SFTPC, ABCA3 and NKX2-1 defects disturb surfactant production, a different disease that only looks alike

Prognosis

Autoimmune proteinosis has a good outlook with lavage and GM-CSF, with five-year survival above 90%; some cases remit on their own and others need repeated lavage. Secondary proteinosis depends on its cause and is worse with blood cancers; congenital surfactant disorders are often severe in infants.

Test yourself

Think of the answer, then tap the question to see it.

What causes most cases of pulmonary alveolar proteinosis?

Autoantibodies that neutralise GM-CSF, so alveolar macrophages cannot mature and clear surfactant.

What is the classic high-resolution CT pattern?

Crazy paving: ground-glass opacity with thickened interlobular septa, with sharp geographic borders and spared lobules.

What does bronchoalveolar lavage look like in this disease?

Milky, opaque fluid with PAS-positive acellular material and foamy macrophages.

What is the standard treatment for symptomatic disease?

Whole-lung lavage under general anaesthesia; inhaled GM-CSF is an option in the autoimmune form.

A 42-year-old smoker has 8 months of worsening exertional breathlessness, no fever. CT: bilateral ground glass, thickened septa, sharp geographic borders. Which blood test is most useful next?

Serum anti-GM-CSF antibodies: highly sensitive and specific for autoimmune alveolar proteinosis, the likely diagnosis given the crazy paving and the slow course without fever.

Add to my cards (5)

Why it happens

Connections

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Pulmonary Alveolar Proteinosis (StatPearls (NCBI Bookshelf), 2026); Bronchoalveolar Lavage (StatPearls (NCBI Bookshelf), 2024).

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.